Lrig1 Expression in Human Sebaceous Gland Tumors
May 2016
in “
Dermatopathology
”
Studysummary The researchers reported that Lrig1 overexpression was observed in 100% of sebaceous carcinoma cases, suggesting it may serve as a potential marker for poorly differentiated sebaceous carcinoma.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study investigated Lrig1 expression in 28 human sebaceous gland tumors and found significant overexpression in sebaceous carcinomas (100%), sebaceomas (80%), and sebaceous adenomas (43%), but not in sebaceous hyperplasias. This suggested that Lrig1 might play a role in tumor progression and could serve as a potential biomarker for poorly differentiated sebaceous carcinoma. The study also noted an inverse relationship between Lrig1 and CD44v3 expression and highlighted the need for further research due to the small sample size.
